Mylan CEO Gets a Raise as Stock Slides Amid Tumultuous Year

Days before Mylan NV announced an ugly forecast for the year ahead, the generic drugmaker gave its chief executive a raise.

Mylan increased Chief Executive Officer Heather Bresch’s salary by more than 15 percent to $1.5 million and extended her contract through April 21, 2024, according to a document filed with the Securities and Exchange Commission this week. She’s also eligible for a target annual bonus of $2.25 million.

The filing didn’t specify whether she will also receive additional equity awards, which make up the bulk of her compensation. She reaped about $12.7 million in 2017, of which about 70 ...